Absci Corp (ABSI)
4.21
-0.04
(-0.94%)
USD |
NASDAQ |
May 31, 16:00
4.19
-0.02
(-0.48%)
Pre-Market: 20:00
Absci Cash and Short Term Investments (Quarterly): 161.54M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 161.54M |
| December 31, 2023 | 97.66M |
| September 30, 2023 | 113.48M |
| June 30, 2023 | 124.59M |
| March 31, 2023 | 144.26M |
| December 31, 2022 | 164.43M |
| September 30, 2022 | 181.31M |
| Date | Value |
|---|---|
| June 30, 2022 | 206.02M |
| March 31, 2022 | 226.00M |
| December 31, 2021 | 252.57M |
| September 30, 2021 | 279.26M |
| June 30, 2021 | 99.45M |
| March 31, 2021 | 180.76M |
| December 31, 2020 | 69.87M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
69.87M
Minimum
Dec 2020
279.26M
Maximum
Sep 2021
164.37M
Average
162.99M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Eli Lilly and Co | 2.586B |
| Creative Medical Technology Holdings Inc | 9.007M |
| CytomX Therapeutics Inc | 150.28M |
| Bristol-Myers Squibb Co | 9.67B |
| Recursion Pharmaceuticals Inc | 296.33M |